Despite the scarce importance in IBD differentiation, the oncogenic role of miR-142-3p is well known, which promotes cellular invasion in colorectal cancer cells by activating RAC1 and the onco-suppressive activity of miR-26a, and inhibits cell aggressiveness by regulating FUT4 in CRC [65,66]. This evidence concerns the gene RAC1 and colorectal carcinoma.